<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>CTGCT</provider_name><provider_url>https://ctgct.si/en/</provider_url><author_name>Rodrigo Ortiz</author_name><author_url>https://ctgct.si/en/author/rodrigoctgct/</author_url><title>Du&#x161;ko Lain&#x161;&#x10D;ek interviewed by Svet24 - CTGCT</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="Qa090xnHSx"&gt;&lt;a href="https://ctgct.si/en/objave/dusko-lainscek-interviewed-by-svet24/"&gt;Du&#x161;ko Lain&#x161;&#x10D;ek interviewed by Svet24&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://ctgct.si/en/objave/dusko-lainscek-interviewed-by-svet24/embed/#?secret=Qa090xnHSx" width="600" height="338" title="&#x201C;Du&#x161;ko Lain&#x161;&#x10D;ek interviewed by Svet24&#x201D; &#x2014; CTGCT" data-secret="Qa090xnHSx" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://ctgct.si/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://ctgct.si/wp-content/uploads/2026/07/Dusko-interview.jpg</thumbnail_url><thumbnail_width>2944</thumbnail_width><thumbnail_height>2273</thumbnail_height><description>How does a breakthrough gene therapy begin? What does it take to turn a scientific idea into a treatment that can reach a patient?In this interview, Du&#x161;ko Lain&#x161;&#x10D;ek, researcher at the Institute of Chemistry of Slovenia and member of the Centre for the Technologies of Gene and Cell Therapy (CTGCT), shares his journey from veterinary medicine to the forefront of genome editing and gene therapy development. He discusses the promise of CRISPR-based technologies, the challenges of translating research into clinical applications, and the remarkable story behind the development of a pioneering therapy for CTNNB1 syndrome.</description></oembed>
